Zhejiang CONBA Pharmaceutical Co Ltd (600572) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥133.43 Million ≈ $19.52 Million USD) by net assets (CN¥7.16 Billion ≈ $1.05 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang CONBA Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Zhejiang CONBA Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Zhejiang CONBA Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
Zhejiang CONBA Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang CONBA Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Makalot Industrial Co Ltd
TW:1477
|
0.171x |
|
Yunnan Salt & Salt Chemical Industry Co Ltd
SHE:002053
|
0.032x |
|
Qingdao Gaoce Technology Co Ltd
SHG:688556
|
0.024x |
|
PLUXEE NV
PA:PLX
|
0.434x |
|
Mister Car Wash, Inc. Common Stock
NYSE:MCW
|
0.083x |
|
Choice International Limited
NSE:CHOICEIN
|
-0.049x |
|
Metrics Master Income Trust
AU:MXT
|
0.036x |
|
Fagron NV
BR:FAGR
|
0.167x |
Annual Cash Flow Conversion Efficiency for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang CONBA Pharmaceutical Co Ltd from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see 600572 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥6.91 Billion ≈ $1.01 Billion |
CN¥1.01 Billion ≈ $148.16 Million |
0.146x | +19.80% |
| 2023-12-31 | CN¥7.35 Billion ≈ $1.08 Billion |
CN¥898.64 Million ≈ $131.50 Million |
0.122x | -22.50% |
| 2022-12-31 | CN¥7.32 Billion ≈ $1.07 Billion |
CN¥1.16 Billion ≈ $169.08 Million |
0.158x | +31.05% |
| 2021-12-31 | CN¥7.39 Billion ≈ $1.08 Billion |
CN¥889.94 Million ≈ $130.23 Million |
0.120x | -48.47% |
| 2020-12-31 | CN¥5.35 Billion ≈ $782.79 Million |
CN¥1.25 Billion ≈ $182.87 Million |
0.234x | +24.76% |
| 2019-12-31 | CN¥4.94 Billion ≈ $723.27 Million |
CN¥925.50 Million ≈ $135.43 Million |
0.187x | +98.73% |
| 2018-12-31 | CN¥5.79 Billion ≈ $847.64 Million |
CN¥545.78 Million ≈ $79.86 Million |
0.094x | -22.70% |
| 2017-12-31 | CN¥5.84 Billion ≈ $855.11 Million |
CN¥712.27 Million ≈ $104.23 Million |
0.122x | -43.59% |
| 2016-12-31 | CN¥4.49 Billion ≈ $656.77 Million |
CN¥969.71 Million ≈ $141.90 Million |
0.216x | +18.66% |
| 2015-12-31 | CN¥4.57 Billion ≈ $668.05 Million |
CN¥831.26 Million ≈ $121.64 Million |
0.182x | -0.61% |
| 2014-12-31 | CN¥3.37 Billion ≈ $493.18 Million |
CN¥617.43 Million ≈ $90.35 Million |
0.183x | +101.72% |
| 2013-12-31 | CN¥2.59 Billion ≈ $379.22 Million |
CN¥235.36 Million ≈ $34.44 Million |
0.091x | -9.81% |
| 2012-12-31 | CN¥2.44 Billion ≈ $357.14 Million |
CN¥245.76 Million ≈ $35.96 Million |
0.101x | -13.82% |
| 2011-12-31 | CN¥1.61 Billion ≈ $235.90 Million |
CN¥188.36 Million ≈ $27.56 Million |
0.117x | +59.22% |
| 2010-12-31 | CN¥1.72 Billion ≈ $251.12 Million |
CN¥125.93 Million ≈ $18.43 Million |
0.073x | -45.11% |
| 2009-12-31 | CN¥1.15 Billion ≈ $167.90 Million |
CN¥153.39 Million ≈ $22.45 Million |
0.134x | +24.75% |
| 2008-12-31 | CN¥919.66 Million ≈ $134.58 Million |
CN¥98.56 Million ≈ $14.42 Million |
0.107x | +14.52% |
| 2007-12-31 | CN¥854.74 Million ≈ $125.08 Million |
CN¥79.98 Million ≈ $11.70 Million |
0.094x | -17.51% |
| 2006-12-31 | CN¥627.66 Million ≈ $91.85 Million |
CN¥71.20 Million ≈ $10.42 Million |
0.113x | -42.62% |
| 2005-12-31 | CN¥595.08 Million ≈ $87.08 Million |
CN¥117.65 Million ≈ $17.22 Million |
0.198x | +70.62% |
| 2004-12-31 | CN¥565.05 Million ≈ $82.68 Million |
CN¥65.47 Million ≈ $9.58 Million |
0.116x | -58.37% |
| 2003-12-31 | CN¥239.44 Million ≈ $35.04 Million |
CN¥66.64 Million ≈ $9.75 Million |
0.278x | -- |
About Zhejiang CONBA Pharmaceutical Co Ltd
Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nut… Read more